ES8707547A1 - Procedimiento para preparar un oligopeptidil-argininol u-homoargininol o derivado de estos - Google Patents

Procedimiento para preparar un oligopeptidil-argininol u-homoargininol o derivado de estos

Info

Publication number
ES8707547A1
ES8707547A1 ES552086A ES552086A ES8707547A1 ES 8707547 A1 ES8707547 A1 ES 8707547A1 ES 552086 A ES552086 A ES 552086A ES 552086 A ES552086 A ES 552086A ES 8707547 A1 ES8707547 A1 ES 8707547A1
Authority
ES
Spain
Prior art keywords
residue
derivatives
preparation
agents containing
oligopeptidylargininol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552086A
Other languages
English (en)
Other versions
ES552086A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES8707547A1 publication Critical patent/ES8707547A1/es
Publication of ES552086A0 publication Critical patent/ES552086A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

PROCEIDMIENTO PARA LA PREPARACION DE UN OLIGOPEPDITIL-ARGINOL U -HOMOARGININOL O UN DEROVADO DE ESTOS, DE FORMULA GENERAL (I). CONSISTE EN HACER REACCIONAR ENTRE SI DERIVADOS CONOCIDOS Y EVENTUALMENTE ACTIVADOS DE PORCIONES MOLECULARES CONOCIDAS DE UN COMPUESTO DE FORMULA GENERAL (I), PARA LO CUAL LOS DISTINTOS REACCIONANTES PUEDEN PRESENTARSE EN UN EXCESO DE HASTA 10 VECES MOLAR CON RESPECTO AL OTRO REACCIONANTE. DICHOS REACCIONANTES SE DISUELVEN EN UN DISOLVENTE QUE NO PERTURBE LA REACCION DESEADA Y SE AJUSTAN A UN PH COMPRENDIDO DENTRO DEL INTERVALO DE 4,0 A 8,5, EFECTUANDOSE LA REACCION A UNA TEMPERATURA QUE SE CARACTERIZA POR EL PUNTO DE FUSION O DE EBULLICION DEL DISOLVENTE CORRESPONDIENTE. DE APLICACION COMO AGENTES FARMACEUTICOS ALTAMENTE INHIBIDORES DE TROMBINA.
ES552086A 1985-02-18 1986-02-17 Procedimiento para preparar un oligopeptidil-argininol u-homoargininol o derivado de estos Expired ES8707547A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853505555 DE3505555A1 (de) 1985-02-18 1985-02-18 Neue oligopeptidylargininolderivate und deren homologe, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
ES8707547A1 true ES8707547A1 (es) 1987-08-01
ES552086A0 ES552086A0 (es) 1987-08-01

Family

ID=6262841

Family Applications (1)

Application Number Title Priority Date Filing Date
ES552086A Expired ES8707547A1 (es) 1985-02-18 1986-02-17 Procedimiento para preparar un oligopeptidil-argininol u-homoargininol o derivado de estos

Country Status (7)

Country Link
US (1) US4713369A (es)
EP (1) EP0192135A3 (es)
JP (1) JPS61189298A (es)
AU (1) AU589159B2 (es)
CA (1) CA1269200A (es)
DE (1) DE3505555A1 (es)
ES (1) ES8707547A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075634B2 (ja) * 1987-10-30 1995-01-25 日東紡績株式会社 トリペプチド類及びこれを含有する抗プラスミン剤
US4929602A (en) * 1987-11-25 1990-05-29 Scripps Clinic And Research Foundation Method of inhibiting platelet dependent arterial thrombosis
US5023236A (en) * 1988-04-07 1991-06-11 Corvas, Inc. Factor VII/VIIA active site inhibitors
EP0436654A1 (en) 1988-09-30 1991-07-17 The University Of Vermont And State Agricultural College Immunoassays for catalytically-active, serine proteases
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
US5391705A (en) * 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
KR100244418B1 (ko) * 1992-06-18 2000-02-01 슈테펜엘.네스비트 트롬빈 억제제
ATE174036T1 (de) * 1993-03-29 1998-12-15 Du Pont Merck Pharma Prozess und zwischenverbindungen zur herstellung von blaettchen glycoprotein iib/iiia hemmern
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
US5783563A (en) * 1993-06-03 1998-07-21 Astra Aktiebolag Method for treatment or prophylaxis of venous thrombosis
GB9318637D0 (en) * 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
US5821267A (en) * 1993-10-21 1998-10-13 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
WO1995024382A1 (en) * 1994-03-10 1995-09-14 G.D. Searle & Co. L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
DE4436772A1 (de) * 1994-10-14 1996-04-18 Boehringer Mannheim Gmbh Neues Dipeptid-Derivat, Verfahren zu seiner Herstellung sowie diese Verbindung enthaltende Arzneimittel
US5684008A (en) 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
US5612369A (en) * 1995-06-07 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Thrombin inhibitors
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
US6069232A (en) * 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
TW541316B (en) 1995-12-21 2003-07-11 Astrazeneca Ab Prodrugs of thrombin inhibitors
DE19549118C2 (de) * 1995-12-29 2000-07-13 Thomas W Stief Hämostaseaktivierungs-Inhibitor und Verfahren zum Hemmen der Hämostaseaktivierung in Blut oder anderen biologischen Flüssigkeiten
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
FR3015515B1 (fr) 2013-12-19 2016-02-05 IFP Energies Nouvelles Procede de pretraitement d'huiles vegetales par catalyse heterogene de l'esterification des acides gras

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318904A (en) * 1980-04-25 1982-03-09 Research Corporation Peptide affinity labels for thrombin and other trypsin-like proteases
JPS56158753A (en) * 1980-05-08 1981-12-07 Otsuka Pharmaceut Factory Inc Kyotorphin derivative
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
JPS60214768A (ja) * 1984-04-07 1985-10-28 Fujisawa Pharmaceut Co Ltd オリゴペプチド化合物

Also Published As

Publication number Publication date
DE3505555A1 (de) 1986-09-11
EP0192135A3 (de) 1988-08-31
AU589159B2 (en) 1989-10-05
US4713369A (en) 1987-12-15
JPS61189298A (ja) 1986-08-22
EP0192135A2 (de) 1986-08-27
CA1269200A (en) 1990-05-15
ES552086A0 (es) 1987-08-01
AU5372786A (en) 1986-08-21

Similar Documents

Publication Publication Date Title
ES8707547A1 (es) Procedimiento para preparar un oligopeptidil-argininol u-homoargininol o derivado de estos
ES8708237A1 (es) Procedimiento para la preparacion de nuevos aldehidos pep- tidos
IL127352A (en) Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them
ATE137763T1 (de) Peptid-verbindungen, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung
HK1013283A1 (en) Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
IL104716A (en) 7-1-oxo-2- (substituted mercapto)-3- phenylpropyl) amino| octahydro-6-pyrido £2, 1-a| benzazepine- 4-carboxylic acid derivatives and analogs, their preparation and pharmaceutical compositions containing them for inhibiting enkephalinase and ace
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
YU31399A (sh) Inhibitori sintaze azot-monoksida
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
PT80303B (pt) Processo para a preparacao de composicoes para a higiene bucal
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
UA35574C2 (uk) Похідні заміщеної гетероциклом фенілциклогексанкарбонової кислоти, суміші їх ізомерів або окремі ізомери та їх солі
ES8601108A1 (es) Procedimiento para la obtencion de eglinas b o c modificadas
ES8307744A1 (es) Un metodo para la preparacion de nuevos derivados de sales de metales alcalinos de acidos 2-pirrolidon-4-carboxilicos.
ES8800272A1 (es) Un procedimiento para la preparacion de polipeptidos.
EP0460062A4 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
JO1406B1 (en) Chemical compounds
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
ES8106891A1 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
EP0384341A3 (en) New proline derivatives
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
ATE83242T1 (de) Cysteinreiche, gamma-glutaminsaeure und betaalanin-einheitenaufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
ZA9710960B (en) Substituted tetrahydropyridine compounds, process for preparing them and pharmaceutical compositions containing them.